In PracticeBalancing Nutrition and Serum Phosphorus in Maintenance Dialysis
Section snippets
Case presentation
A 63-year-old white man with stage 5D chronic kidney disease (CKD) started on maintenance hemodialysis (HD) therapy 2.5 years ago. He presents with the following laboratory measurements (fasting midweek predialysis): serum phosphorus, 6.2 mg/dL (1.90 mmol/L); serum calcium, 10.4 mg/dL (2.60 mmol/L); serum parathyroid hormone (PTH), 280 pg/mL; serum 25-hydroxyvitamin D3 (25[OH]D3), 40 ng/mL (100 nmol/L); normalized protein catabolic rate, 1.25 g/kg/d; and serum albumin, 3.8 mg/dL. His medications include
Protein intake and serum phosphorus
A common recommendation for the management of hyperphosphatemia is to reduce the amount of phosphorus in the diet.2 The NKF-KDOQI guidelines and European Best Practice Guidelines recommend daily phosphorus intake of 800-1,000 mg/d for patients on maintenance HD therapy.3, 6, 7 Foods with high protein content tend to have high phosphorus content, and an increase in dietary protein has been shown to correlate with an increase in serum phosphorus levels (Fig 2).8 Limiting dietary phosphorus intake
Inorganic phosphorus
Inorganic phosphorus additives are an often-overlooked source of phosphorus in the diet. Compounds that contain inorganic phosphorus frequently are used in the food industry to extend shelf life, enhance flavor, and improve the color of food products; these additives can make the overall phosphorus content very high.13 However, it is not a requirement that manufacturers list phosphorus content on food packaging, making the exact levels of phosphorus in these foods difficult to determine.
Risks associated with low dietary protein intake
The NKF-KDOQI guidelines suggest that patients receiving HD aim to consume 1.2 g of protein per kilogram per day, and the European Best Practice Guidelines recommend at least 1.1 g of protein per kilogram per day.4, 7 However, a study of 53,933 patients receiving HD in clinics across the United States showed that >50% of these patients consumed less than this amount.16 This study further demonstrated that a spontaneous decrease in protein consumption in patients with a normalized protein-nitrogen
Phosphate-binder use and adequate nutrition
By reducing the amount of dietary phosphorus absorbed from the gut, phosphate binders help control serum phosphorus levels and are used by 78%-88% of patients receiving HD.1, 18 Table 1 compares binding capacities and dosages of 4 of the leading phosphate binders in the United States: calcium acetate, calcium carbonate, sevelamer carbonate, and lanthanum carbonate. The values presented are estimates of the dosage that would be required in order to control a relatively modest increase in
Additional benefits associated with phosphate binders
One of the complications of CKD is an increased risk of heart disease, and a key risk factor for heart disease is vascular calcification. Although the pathogenesis of vascular calcification in patients with CKD is thought to be multifactorial, hyperphosphatemia is an important risk factor.20 In certain patients, hypercalcemia also may contribute to the progression of calcification, and recent guidelines have suggested that the use of calcium-based phosphate binders is not recommended for some
Phosphate binders in clinical practice
One of the key challenges in the treatment of chronic diseases is patients' adherence to their diet and drug regimen. The majority of patients on maintenance HD therapy require phosphate binders; however, on average, 51% of patients are not fully adherent to their prescribed phosphate-binder therapy.37 It therefore is important to consider how best to help patients with CKD follow their often complex therapy regimens.
There are no clear demographic predictors of nonadherence. In a systematic
Conclusions
Restricting dietary protein to help control phosphorus levels in patients undergoing maintenance HD may be more harmful than beneficial. More importantly, increased awareness of inorganic phosphorus in food additives may lead to significant improvements in dietary phosphorus restriction regimens.
Phosphate binders help maintain serum phosphorus levels in the recommended ranges and have beneficial effects in terms of reducing calcification and serum FGF-23 levels. In addition, taking phosphate
Acknowledgements
Support: This article is based on information presented at a Shire-sponsored symposium, Clinical Challenges in Balancing Nutritional Intake and Phosphate Metabolism in Dialysis Patients, held at the European Renal Association–European Dialysis and Transplant Association Congress 2012 (ERA–EDTA 2012, Paris, France, May 25-27, 2012). Rosalind Morley at PharmaGenesis London provided medical writing services funded by Shire, including full editorial support, collating information from the
References (42)
- et al.
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?
Am J Clin Nutr
(2008) - et al.
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease
Kidney Int
(2008) - et al.
Effect of boiling on dietary phosphate and nitrogen intake
J Ren Nutr
(2006) - et al.
Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients
J Ren Nutr
(2011) Hidden phosphorus in popular beverages: part 1
J Ren Nutr
(2005)- et al.
Longitudinal associations between dietary protein intake and survival in hemodialysis patients
Am J Kidney Dis
(2006) - et al.
Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status
Am J Kidney Dis
(2012) - et al.
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
Lancet
(2013) - et al.
The combination of lanthanum chloride and the calcimimetic calindol delays the progression of vascular smooth muscle cells calcification
Biochem Biophys Res Commun
(2012) - et al.
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
Kidney Int
(2005)
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
Kidney Int
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial
Am J Kidney Dis
Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?
Nephrol Dial Transplant
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
Kidney Int Suppl
Eleven reasons to control the protein intake of patients with chronic kidney disease
Nat Clin Pract Nephrol
K/DOQI clinical practice guidelines for nutrition in chronic renal failure
Am J Kidney Dis
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Am J Kidney Dis
EBPG guideline on nutrition
Nephrol Dial Transplant
Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease
Clin J Am Soc Nephrol
Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation
Nephron
Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease
Clin J Am Soc Nephrol
Cited by (61)
Novel Protein to Phosphorous Ratio Score Predicts Mortality in Hemodialysis Patients
2022, Journal of Renal NutritionUsing modified quartz sand for phosphate pollution control in cemented phosphogypsum (PG) backfill
2021, Journal of Cleaner ProductionCitation Excerpt :It is well known that excessive phosphate input can cause eutrophication, therefore imposing adverse influences on water quality as well as the health of aquatic plants and animals (Alimov and Golubkov, 2014; Li et al., 2015). Through the biological circulation, phosphate then enters the human body, causing disruption of bone metabolism and heart disease (Fouque et al., 2014). As a result, the reuse of PG as the aggregate for cemented backfill must consider the potential phosphate pollution to the environment and humankind.
Differences and Effects of Metabolic Fate of Individual Amino Acid Loss in High-Efficiency Hemodialysis and Hemodiafiltration
2020, Journal of Renal NutritionCitation Excerpt :After 12 months' follow-up, a deterioration in AA plasma levels was highlighted: with the exception of glutamine, all other AAs displayed reduced plasma concentrations, with the phenomenon particularly evident in the reduction of lysine, a fundamental essential amino acid, the concentration of which was lower than that observed in healthy controls. An increase in catabolic processes is sustained by at least three factors supporting this hypothesis: (1) Both hypercatabolism and anabolism are metabolic processes that require extensive availability of energy (particularly in the form of ATP), the production of which is based on AA activity within the cell cycle of tricarboxylic acids.64 A further deterioration of lean body mass at 12 months was clearly the result of an increase in catabolic processes, particularly in lean muscle tissue; (2) indeed, an important role in muscle catabolism is played by metabolic acidosis, notably in the presence of uncompensated acidosis, as the former stimulates the ubiquitin-proteasome pathway of protein degradation14; (3) although no nutritional supplementation was prescribed throughout the study, glutamine was found to have increased significantly after 12 months' follow-up, with the increase detected in our study being a direct consequence of the intense buffer activity of ammonia on skeletal muscle produced through proteolysis and oxidation of AAs, as well as through the nucleotide metabolism in messengers such as cyclic adenosine monophosphate and cyclic guanosine monophosphate needed to ensure regular functioning of the Krebs cycle and transduction of cell signals, ionic conductance channels, and glycogenolysis.
Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia
2018, Nephrologie et TherapeutiqueDietary Intervention in Phosphatemia Control–Nutritional Traffic Light Labeling
2018, Journal of Renal NutritionEvaluation of objective nutritional indexes as predictors of worse outcomes in peritoneal dialysis patients
2020, NutritionCitation Excerpt :One possible reason is that most patients undergoing PD at our center have controlled serum phosphate levels within the normal range. Patients can manage phosphorus intake through dietary protein restriction, but this can result in PEW that, in turn, is associated with increased mortality [30]. Another highlight of our study is that we converted the nutritional index from a continuous to a categorical variable (cutoff value).